HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody 17-1A (Edrecolomab)

anticolorectal carcinoma antibody for treatment of advanced colorectal carcinoma; in clinical trials 11/1999
Also Known As:
Edrecolomab; MAb 17-1A
Networked: 111 relevant articles (9 outcomes, 26 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goldberg, Richard M: 3 articles (05/2013 - 06/2005)
2. Niedzwiecki, Donna: 2 articles (05/2013 - 08/2011)
3. Bertagnolli, Monica M: 2 articles (05/2013 - 08/2011)
4. Warren, Robert S: 2 articles (05/2013 - 08/2011)
5. Mellstedt, Håkan: 2 articles (12/2010 - 07/2003)
6. Liljefors, Maria: 2 articles (12/2010 - 07/2003)
7. Kufer, Peter: 2 articles (01/2010 - 07/2002)
8. Riethmüller, Gert: 2 articles (01/2010 - 07/2002)
9. Raum, Tobias: 2 articles (01/2010 - 07/2002)
10. Baeuerle, Patrick A: 2 articles (01/2010 - 07/2002)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Neoplasms (Cancer)
3. Residual Neoplasm
4. Colonic Neoplasms (Colon Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. monoclonal antibody 17-1A (Edrecolomab)
2. Interleukin-2 (IL2)
3. Interferon-gamma (Interferon, gamma)
4. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
5. tumor-associated antigen GA733
6. Interferon-alpha (Interferon Alfa)
7. Cytokines
8. Macrophage Colony-Stimulating Factor
9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
10. Antigens

Related Therapies and Procedures

1. Radiotherapy
2. Therapeutics
3. Immunotherapy
4. Drug Therapy (Chemotherapy)
5. Heterologous Transplantation (Xenotransplantation)